The latest information on the Coronavirus outbreak from Greater Manchester Cancer .
This page is intended for GM clinicians. It was last updated at 14:51 on 18 May 2020.
Information from Greater Manchester Cancer
The Greater Manchester Cancer team is currently reviewing all NHS and Government guidance and working with local providers to provide support over the coming weeks. The latest information for clinicians and patients will continue to be posted here as a clear point of reference. Please bear with us whilst we update this page.
GM Cancer Clinicians Online Forum
Greater Manchester Cancer has developed a secure online forum for clinicians to share guidance and discuss various information regarding their pathways or systems. Use the button below to access the forum. If you do not yet have a user login, please register via the button below and we will authorise your account. Once in the online forum, you can request access to a number of groups including any specific pathways you may be part of.
The ‘Cancer’ Hub in Greater Manchester
High-level information on the new cancer hub developed in Greater Manchester can be found on The Christie NHS Foundation Trust website, by clicking here.
Guidance documents regarding the management and processes of the hub can be accessed via the GM Cancer Clinicians online forum, above.
For more information regarding referrals to the Cancer Hub, or to find the nominated operational and clinical lead for your Provider, please contact: Greatermanchester.firstname.lastname@example.org
For information regarding the hub delivery group, contact the above email, for attention of Freya Howle or Alison Armstrong.
NHSE Guidance (cancer-specific)
Speciality Guide (Cancer and Coronavirus) (published 17.03.20) on managing referrals: Click here
Information for Cancer Alliances on managing cancer referrals (last updated 19.03.20): Click here
Information for patients (last updated 19.03.20): Click here
NHS Coronavirus advice for clinicians and NHS managers (non-cancer specific): Click here
New NICE Guidance NG161 – SACT – Published March 2020
COVID-19 rapid guideline: delivery of systemic anticancer treatments: click here for the latest NICE guidance
New NICE Guidance NG162 – Radiotherapy – Published March 2020
COVID-19 rapid guideline: delivery of radiotherapy: click here for the latest NICE guidance
Government information on ‘shielding’ vulnerable persons (includes cancer)
On 22.03.20 the Government announced plans to ‘shield’ those most vulnerable to COVID-19 through a number of measures. This includes people with specific cancers, including:
- people with cancer who are undergoing active chemotherapy or radical radiotherapy for lung cancer
- people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
- people having immunotherapy or other continuing antibody treatments for cancer
- people having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
- people who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
Changes to the Prehab4Cancer Programme
The Prehab4Cancer programme has temporarily suspended face to face sessions with patients. Patients are being supported via telephone consultations. For more details information and for downloadable leaflets for patients, visit the Prehab page of our website here.
Latest NHS and Government Guidance (general advice for the public)
Information to give to the public
Patients can find a link to information from NHSEI from our homepage gmcancer.org.uk.